Since 1997, the Romanian government and Merck & Co., Inc. have worked together to increase access to treatment for thousands of children and adults living with HIV/AIDS in Romania. Through this partnership, the number of patients with access to therapy has increased dramatically.
While in 1997 only about 1.5 percent of treated patients received triple combination antiretroviral (ARV) therapy in accordance with international standards, today the Romanian government has achieved its goal of providing access to ARV therapy to all HIV/AIDS patients in Romania in need of treatment. Today, of the almost 8,000 patients in active monitoring, more than 6,000 are being treated. This represents all patients who need ARV treatment under international guidelines.
To learn more about Merck's commitment to addressing HIV/AIDS, click on the links below:
